Litigation Summary and Analysis for Supernus Pharmaceuticals, Inc. v. Creekwood Pharmaceuticals, LLC | 1:25-cv-00880
Introduction
Supernus Pharmaceuticals, Inc. (“Supernus”) initiated litigation against Creekwood Pharmaceuticals, LLC (“Creekwood”) in the district court under case number 1:25-cv-00880. The dispute centers on alleged patent infringement relating to a drug formulation and associated intellectual property rights. This legal confrontation underscores the strategic importance of patent portfolio management and enforcement within the pharmaceutical industry.
Case Background
Supernus, a recognized leader in developing neuropharmacological therapeutics, holds multiple patents protecting its proprietary formulations. Creekwood, a lesser-known pharmaceutical firm, entered the market with a competing product, prompting Supernus to pursue legal remedies.
According to court filings, Supernus asserts that Creekwood’s product infringes on its U.S. Patent No. [specific patent number], granted on [grant date], covering a novel extended-release formulation for [specific indication]. Supernus contends that Creekwood’s product utilizes the patented formulation or a substantially similar invention, violating patent rights and causing market dilution.
The dispute gained intensity when Supernus filed a complaint requesting injunctive relief, monetary damages,…
